InsidersTradesSigma
Track the AstraZeneca PLC share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, AstraZeneca PLC has recorded 10 reports. Market capitalisation: €185.6bn. The latest transaction was reported on 18 September 2026 (Purchase). Among the most active insiders: Aradhana Sarin. Every trade is free.
Analysts rate AstraZeneca PLC Buy (bullish), based on 22 analysts. Average price target: £15,699.59.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
AstraZeneca PLC is a global pharmaceutical company focused on the research, development, and commercialization of drugs in the fields of oncology, cardiovascular, and respiratory diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Pascal Soriot bought 60,000 AstraZeneca shares for about £7.26m as Europe drug news, valuation and rate pressure frame t...
AstraZeneca rose on mixed oncology data, with SERENA-4 missing and Enhertu and Tagrisso helping. Insider activity remain...
Tezspire data, a €2.55bn bond and a mixed oncology week keep AstraZeneca in focus as the sector trades on trial wins and...
AstraZeneca trades with healthcare inflows and a fresh trial setback, while the only recent insider move was a small Aug...